Xue-Yan Kui
Overview
Explore the profile of Xue-Yan Kui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Zeng J, Liu X, Gao Y, Kui X, Liu X, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:1013238.
PMID: 36299451
Background: The targeted therapy for lung cancer relies on prognostic genes and requires further research. No research has been conducted to determine the effect of endothelin-converting enzyme 2 (ECE2) in...
2.
Liu X, Gao Y, Kui X, Liu X, Zhang Y, Zhang Y, et al.
J Transl Med
. 2022 Oct;
20(1):450.
PMID: 36195940
Background: The aim of this study was to determine the expression and function of heterogeneous nuclear ribonucleoprotein R (HNRNPR) in esophageal carcinoma (ESCA), the correlation between its expression and F-fluorodeoxyglucose...
3.
Kui X, Gao Y, Liu X, Zeng J, Yang J, Zhou L, et al.
Front Oncol
. 2022 Aug;
12:809847.
PMID: 35957868
Background: Solute carrier family 17 member 9 (SLC17A9) encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. SLC17A9 is involved in...
4.
Liu X, Kui X, Gao Y, Chen X, Zeng J, Liu X, et al.
Front Genet
. 2022 Apr;
13:835265.
PMID: 35401696
YTHDF1 is highly expressed in multiple tumors and affects tumor progression. However, there are only a few comprehensive studies on the analysis of YTHDF1 in esophageal cancer. We analyzed YTHDF1...
5.
Liu X, Yang J, Zeng J, Chen X, Gao Y, Kui X, et al.
Front Cell Dev Biol
. 2022 Apr;
10:853596.
PMID: 35399515
Overexpression of solute carrier family 2 member 1 (SLC2A1) promotes glycolysis and proliferation and migration of various tumors. However, there are few comprehensive studies on SLC2A1 in colorectal cancer (CRC)....
6.
Liu X, Zhou L, Yuan L, Gao Y, Kui X, Liu X, et al.
Front Immunol
. 2021 Sep;
12:751004.
PMID: 34531879
[This corrects the article DOI: 10.3389/fimmu.2021.724741.].
7.
Yang J, Yuan L, Gao Y, Liu X, Wang Y, Zhou L, et al.
J Cancer
. 2021 Sep;
12(19):5838-5847.
PMID: 34475997
We sought to investigate whether the expression of the gene EIF2S2 is related to F-FDG PET/CT metabolic parameters in patients with colorectal cancer (CRC). The expression of EIF2S2 in CRC...
8.
Liu X, Zhou L, Yuan L, Gao Y, Kui X, Liu X, et al.
Front Immunol
. 2021 Aug;
12:724741.
PMID: 34335635
Background: Overexpression of NPM1 can promote the growth and proliferation of various tumor cells. However, there are few studies on the comprehensive analysis of NPM1 in lung adenocarcinoma (LUAD). Methods:...
9.
Liu X, Gao Y, Wu L, Wan H, Yan P, Jin Y, et al.
Front Oncol
. 2021 Jun;
11:665388.
PMID: 34123828
Background: Glucose transporter 1 (GLUT1) is encoded by the solute carrier family 2A1 (SLC2A1) gene and is one of the glucose transporters with the greatest affinity for glucose. Abnormal expression...
10.
Liu X, Gao Y, Liu C, Chen X, Zhou L, Yang J, et al.
Front Oncol
. 2021 Feb;
10:606735.
PMID: 33604289
Background: E2F transcription factors (E2Fs) are a group of genes encoding a family of transcription factors in higher eukaryotes. They are involved in a variety of cellular functions and are...